Advertisement

Topics

A Debate on the Future of Parenteral Drug Delivery and Combination Products

22:00 EST 1 Dec 2016 | PR.com

London, United Kingdom, December 02, 2016 --(PR.com)-- What path is the industry following on the road to patient centric drug delivery? What technical challenges present obstacles in developing and manufacturing combination products? Are market leaders taking advantage of new opportunities in wearable injector technology? How is safety incorporated in the design of a syringe?

SMi Group will invite participants at the 9th annual Pre-Filled Syringes Europe show, which attracts over 100 senior PFS professionals, to join two topical debates led by some of the industries most experienced KOL's.

Day 1 Panel Discussion: Combination Products - Challenges & Opportunities
Moderated by Aphons Fakler, Group Head Risk Management, Novartis

Speakers:
Serkan Oray, Senior Director, Device & Technology, UCB
David Ottolangui, Device Technology Director, GSK
Ed Cahill, Senior Director, Technical & Scientific Affairs - Sterile Products, Teva

The in-depth discussion on combination products will delve further into manufacturing, regulations and patient interaction to promote safety and adherence to products.

Day 2 Panel Discussion: The Future of Parenteral Drug Delivery. Moving from Drug Delivery Devices to Therapy Management Ecosystems
Moderated by Aphons Fakler, Group Head Risk Management, Novartis

Speaker:
Ignace Wallaert, Principle Scientist Packaging Development, Janssen
Attendees will discuss new windows of opportunity in injectable technology as well as best practise in switching to needle-free delivery systems. The debate will allow participants to share their experiences in overcoming industry obstacles and will explore pens versus pumps.

The panel debates will follow a day of keynote presentations from an array of senior PFS industry leaders from big pharma, government bodies and top manufacturers including MHRA, Behringher Ingelheim, GSK, Sanofi, Nipro PharmaPackaging, F.Hoffman Roche, Glenmark Pharmaceuticals, Medical Device Usability, Sandoz, Terumo Pharmaceutical Solutions, and Novartis.

Further information including a full speaker line-up and conference agenda is available online at www.pre-filled-syringes.com

Pre-Filled Syringes Europe 2017
9th Annual Conference: 18th & 19th Jan | Interactive Workshops: 17th Jan
Copthorne Tara Hotel, Kensington, London UK
www.pre-filled-syringes.com

Follow the conversation on LinkedIn and Twitter at #pfssmi

Sponsored by: Datwyler, Früh Verpackungstechnik Ag, Medical Device Usability, Mitsubishi Gas Chemical, Owen Mumford, Mikron Automation, Nemera, Nipro Pharmapackaging, Terumo Pharmaceutical Solutions, West Pharmaceutical Services, Worrell, Zeon

Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk

To register for the conference, visit www.pre-filled-syringes.com or contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk

To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Contact Information:
SMi Group
Teri Arri
+44 (0) 20 7827 6038
Contact via Email
http://www.pre-filled-syringes.com/prcom

Read the full story here: http://www.pr.com/press-release/697249

Press Release Distributed by PR.com

Original Article: A Debate on the Future of Parenteral Drug Delivery and Combination Products

NEXT ARTICLE

More From BioPortfolio on "A Debate on the Future of Parenteral Drug Delivery and Combination Products"

Quick Search
Advertisement
 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...